medicine Product List and Ranking from 36 Manufacturers, Suppliers and Companies

Last Updated：Jan 21, 2026 Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated：Jan 21, 2026 Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

マーケットリサーチセンター Tokyo//Service Industry
プレシジョン・システム・サイエンス Chiba//Pharmaceuticals and Biotechnology
null/null
4 Tohoku Techno Arch Co., Ltd. Miyagi//Educational and Research Institutions
5 バイオマテックジャパン Hokkaido//Pharmaceuticals and Biotechnology

Go to Company Ranking

medicine Product ranking

Last Updated：Jan 21, 2026 Aggregation Period:Dec 24, 2025～Jan 20, 2026
This ranking is based on the number of page views on our site.

Reagent for Fully Automatic Nucleic Acid Extraction Device MagDEA Dx SV プレシジョン・システム・サイエンス
Pharmaceutical CDMO services 大塚化学
Ouchi Shinko Chemical Industry Co., Ltd. 須賀川市経済環境部商工課
Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
4 Natural Proteoglycan, the Herbal Medicine of the Sea バイオマテックジャパン

medicine Product List

61～75 item / All 600 items

Displayed results

Clinical Trial: Achondroplasia

RBM-007 strongly suggests that it could be a new drug for cartilage dysplasia!

We would like to introduce the clinical trials conducted by our company. The project concerning achondroplasia received support from the Japan Agency for Medical Research and Development (AMED) and began a Phase 1 trial in July 2020 at a domestic clinical trial facility to investigate the safety, tolerability, and pharmacokinetics of RBM-007, which was conducted until May 2021. Regarding the Phase 2 trial of this project, it has been adopted as a pre-commercialization support project for orphan drugs by AMED for three years starting from the fiscal year 2021. [Main Trials] ■ Phase 1 Clinical Trial ■ Early Phase 2 Observational Trial ■ Early Phase 2 Clinical Trial ■ Early Phase 2 Long-term Clinical Trial *For more details, please refer to the PDF materials or feel free to contact us.

Company：リボミック
Price：Other

Other Testing Contract

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Do you feel down in winter? It's called "winter blues"!

Thorough explanation of causes and countermeasures!

As it gets cold during this time of year, some people may find themselves feeling down, saying things like "I just feel gloomy" or "I have no motivation to do anything..." This might be what is known as "winter blues." It has symptoms similar to depression and is more likely to occur in winter, which is why it is also called "seasonal affective disorder." In this article, we will explain in detail the symptoms, causes, and ways to improve "winter blues." *You can read the continuation of the article through the related link (our company website).

Company：デラ
Price：Other

Other services
others
Other office supplies

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Antifungal Drugs for Candidiasis

World Market for Candidiasis Treatment Drugs: Doxorubicin, Cisplatin, Carboplatin, Etoposide, Ifosfamide, Cyclophosphamide ...

This research report (Global Candidiasis Therapeutics Market) investigates and analyzes the current state and future outlook of the global market for candidiasis treatment drugs over the next five years. It includes information on the overview of the global candidiasis treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include doxorubicin, cisplatin, carboplatin, etoposide, ifosfamide, cyclophosphamide, methotrexate, and vincristine, while the segments by application focus on multi-specialty hospitals, cancer research institutes, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for candidiasis treatment drugs. The report also includes the market share of major companies in the candidiasis treatment drug sector, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services
Technical and Reference Books

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Erectile Dysfunction Treatment Drugs

Global Market for Erectile Dysfunction Treatment Drugs: Sildenafil, Tadalafil, Others, Hospital Pharmacies, Private Clinics, Retail Pharmacies, E-commerce (B2B) ...

This research report (Global Erectile Dysfunction Drugs Market) investigates and analyzes the current state and outlook for the global market of erectile dysfunction treatment drugs over the next five years. It includes information on the overview of the global erectile dysfunction treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include sildenafil, tadalafil, and others, while the segments by application cover hospital pharmacies, private clinics, retail pharmacies, e-commerce (B2B), and e-commerce (B2C). The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of erectile dysfunction treatment drugs. It also includes the market share of major companies in the erectile dysfunction treatment drug sector, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Testicular Cancer Treatment

Global Market for Testicular Cancer Treatment: Injectables, Oral Medications, Hospital Pharmacies, Retail Pharmacies, Specialized Cancer Clinics, Others

This research report (Global Testicular Cancer Treatment Market) investigates and analyzes the current state and future outlook of the global testicular cancer treatment market over the next five years. It includes information on the overview of the global testicular cancer treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include injectable and oral medications, while the segments by application cover hospital pharmacies, retail pharmacies, specialized cancer clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for testicular cancer treatment. It also provides information on the market share of major companies in testicular cancer treatment, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for the Treatment of HIV-Related Lipodystrophy Syndrome

Global Market for HIV-Related Lipodystrophy Syndrome Treatment: Specific Drug Treatments, Cosmetic Correction Treatments, Hospitals, Specialist Clinics, Others

This research report (Global HIV Associated Lipodystrophy Syndrome Treatment) investigates and analyzes the current state and outlook for the global market for HIV-associated lipodystrophy syndrome treatment over the next five years. It includes information on the overview of the global HIV-associated lipodystrophy syndrome treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on specific drug treatments and cosmetic corrective treatments, while the segments by application target hospitals, specialist clinics, and others. The regional segments calculate the market size for HIV-associated lipodystrophy syndrome treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in HIV-associated lipodystrophy syndrome treatment, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Blood Treatments

Global Market for Blood Treatment: OTC, Prescription Drugs, Hospitals, Drugstores, Others

This research report (Global Hematology Treatment Market) investigates and analyzes the current state of the global hematology treatment market and its outlook for the next five years. It includes information on the overview of the global hematology treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the hematology treatment market focus on OTC and prescription drugs, while the segments by application target hospitals, drugstores, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for hematology treatment. It also includes the market share of major companies in hematology treatment, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Medical Mouthwash

World Market for Medical Mouthwash: Fluoride Mouthwash, Cosmetic Mouthwash, Disinfectant Mouthwash, Natural Mouthwash, Total Care Mouthwash, Home, Commercial ...

This research report (Global Medical Mouthwash Market) investigates and analyzes the current state and outlook for the global medical mouthwash market over the next five years. It includes information on the overview of the global medical mouthwash market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the medical mouthwash market include fluoride mouthwash, cosmetic mouthwash, antiseptic mouthwash, natural mouthwash, and total care mouthwash, while the segments by application focus on home, commercial, and clinic uses. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size of medical mouthwash. It also includes the market share of major companies in the medical mouthwash sector, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Hypertrophic Scars and Keloid Scar Treatment

Global Market for Hypertrophic and Keloid Scar Treatment: Topical Products, Laser Products, Injectables, Others, Hospitals, Clinics, Others

This research report (Global Hypertrophic and Keloid Scar Treatment Market) investigates and analyzes the current state and outlook for the global market for hypertrophic and keloid scar treatments over the next five years. It includes information on the overview of the global hypertrophic and keloid scar treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include topical products, laser products, injectables, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for hypertrophic and keloid scar treatments. It also includes the market share of major companies in hypertrophic and keloid scar treatment, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Ankylosing Spondylitis Treatment

Global Market for Ankylosing Spondylitis Treatment: Disease-Modifying Antirheumatic Drugs (DMARDs), Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Biological Agents, Juvenile, Adult

This research report (Global Ankylosing Spondylitis Treatment Market) investigates and analyzes the current status and outlook for the global market for ankylosing spondylitis treatment over the next five years. It includes information on the overview of the global ankylosing spondylitis treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the ankylosing spondylitis treatment market focus on disease-modifying antirheumatic drugs (DMARDs), non-steroidal anti-inflammatory drugs (NSAIDs), and biological products, while the segments by application target young adults and adults. The regional segments calculate the market size for ankylosing spondylitis treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in ankylosing spondylitis treatment, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] The Global Market for Stroke Treatment

Global Market for Stroke Treatment: Ischemic Stroke, Hemorrhagic Stroke, Hospital Pharmacies, Retail Pharmacies, Online Sales

This research report (Global Stroke Treatment Market) investigates and analyzes the current state of the global stroke treatment market and its outlook for the next five years. It includes information on the overview of the global stroke treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the stroke treatment market focus on ischemic stroke and hemorrhagic stroke, while the segments by application target hospital pharmacies, retail pharmacies, and online sales. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for stroke treatment. It also includes the market share of major companies in stroke treatment, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for the Treatment of Necrotizing Skin Infections

Global Market for Treatment of Necrotizing Skin Infections: Surgery, Antibiotics, Hospitals, Clinics, Outpatient Surgery Centers, Others

This research report (Global Necrotizing Skin Infections Treatment Market) investigates and analyzes the current state and outlook for the global market for necrotizing skin infection treatments over the next five years. It includes information on the overview of the global necrotizing skin infection treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type focus on surgery and antibiotics, while the segments by application target hospitals, clinics, outpatient surgery centers, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for necrotizing skin infection treatments. It also includes the market share of major companies in necrotizing skin infection treatments, product and business overviews, and sales performance.

Company：マーケットリサーチセンター
Price：Other

Other services

View product details

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

[Research Material] Global Market for Peptide Cancer Therapeutics

Global Market for Peptide Cancer Therapeutics: Goserelin, Bortezomib, Leuprolide, Others, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

This research report (Global Peptide Based Cancer Therapeutics Market) investigates and analyzes the current status and outlook for the global market of peptide cancer therapeutics over the next five years. It includes information on the overview of the global peptide cancer therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the peptide cancer therapeutics market include Goserelin, Bortezomib, Leuprolide, and others, while the segments by application focus on hospital pharmacies, retail pharmacies, and online pharmacies. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of peptide cancer therapeutics. It also includes the market share of major companies in peptide cancer therapeutics, product and business overviews, and sales performance.